Results 201 to 210 of about 30,412 (236)
Some of the next articles are maybe not open access.
Autoimmune Pathogenesis and Autoimmune Hemolytic Anemia
Seminars in Hematology, 2005Autoimmune hemolytic anemia (AIHA) is an autoimmune disorder in which autoantibodies are directed against an individual's own red blood cells (RBCs), leading to enhanced clearance through Fc receptor (FcR)-mediated phagocytosis. Although there is a large literature relating to clinical aspects of AIHA, relatively little work addresses how IgG ...
John W, Semple, John, Freedman
openaire +2 more sources
Human Pathology, 1983
Nowhere in the management of patients with autoimmune hemolytic anemias is the communication between clinician and laboratory personnel more important than in regard to blood transfusion. A clinical decision that blood transfusion is necessary must be tempered by the knowledge that transfusion has a greater-than-usual risk in this setting, both because
openaire +2 more sources
Nowhere in the management of patients with autoimmune hemolytic anemias is the communication between clinician and laboratory personnel more important than in regard to blood transfusion. A clinical decision that blood transfusion is necessary must be tempered by the knowledge that transfusion has a greater-than-usual risk in this setting, both because
openaire +2 more sources
Warm Autoimmune Hemolytic Anemia
Hematology/Oncology Clinics of North America, 2015Warm autoimmune hemolytic anemia (AIHA) is defined as the destruction of circulating red blood cells (RBCs) in the setting of anti-RBC autoantibodies that optimally react at 37°C. The pathophysiology of disease involves phagocytosis of autoantibody-coated RBCs in the spleen and complement-mediated hemolysis.
openaire +2 more sources
Autoimmune hemolytic anemia (AIHA) encompasses a group of diseases mostly mediated by autoantibodies against erythrocyte surface antigens. This chapter will address the individual subtypes of AIHA with respect to epidemiology, pathogenesis, diagnostic procedure, clinical features, and therapy.
Meritxell Nomdedeu +5 more
openaire +3 more sources
Meritxell Nomdedeu +5 more
openaire +3 more sources
[Autoimmune hemolytic anemia].
Pathologie-biologie, 1989Autoimmune hemolytic anemias are a heterogenous group of disorders as evidenced by the multiple forms and classifications they have been commonly subjected to: acute or chronic, idiopathic or symptomatic, clinically latent or expressed, due to warm or cold autoantibodies.
openaire +1 more source
[Autoimmune hemolytic anemia].
Ryoikibetsu shokogun shirizu, 2001From the beginning of the century, autoimmune haemolytic anaemia (AIHA) was the first model of an auto-antibody mediated disease. Despite the variety of the clinical features, the diagnosis of AIHA provides few difficulties since the introduction of the popular Coombs' test.
openaire +3 more sources
TNF receptor 2 pathway: drug target for autoimmune diseases
Nature Reviews Drug Discovery, 2010Denise Faustman
exaly
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
New England Journal of Medicine, 2002Jean-François Bach
exaly